By Stephen Nakrosis
Blank-check company Valuence Merger Corp. I filed for a $200 million initial public offering on Wednesday.
The company said it would concentrate on identifying a potential business combination partner "developing breakthrough technology in life sciences and/or advancing a platform for sustainable technology."
It also said, "we will not pursue or consummate our initial business combination with any entity with its principal business operations in China, Hong Kong or Macau.
Valuence Merger Corp. I said its sponsor, Valuence Capital LLC, is affiliated with investment fund Valuence Partners LP.
The company said director nominee Dr. Joong Myung Cho is founder, chairman and chief executive of CrystalGenomics Inc., and Sung Yoon Woo, its CEO and director, is founder and CEO of Credian Partners Inc.
Valuence Merger Corp. I said it applied to list its units on the Nasdaq Global Market under the symbol VMCAU.
SVB Leerink is listed as the offering's sole book-running manager and Baird is listed as lead manager.
Write to Stephen Nakrosis at stephen.nakrosis@wsj.com